Add to Favorites Newsroom RSS Share
fb-shareSbarro Health Research Organization (SHRO)
Philadelphia, PA USA

Our News on Newswise

Potential to Better Treat Mesothelioma Revealed by Precision Medicine Research

Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.
4-Feb-2019 11:45 AM EST Add to Favorites

Metastatic Breast Cancer Survival Improves with New CDK-Inhibitor Plus Endocrine Therapy

A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival
11-Dec-2018 7:55 AM EST Add to Favorites


SHRO Partners with Film Festival to Recognize Importance of Virtual Reality in Medicine and Celebrate Italian-Origin Filmmakers

This week, SHRO partners with the Italian Movie Award International Film Festival to support Italian-American work in cinema, particularly in recognition for accomplishments with the use of Virtual Reality (VR) in applications in medicine
10-Dec-2018 2:05 PM EST Add to Favorites


Italian-American Foundation Honors Antonio Giordano, MD, PhD Founder & President of Sbarro Health Research Organization

Italian-American Foundation, Filitalia, honors Antonio Giordano, MD, PhD, Founder & President of Sbarro Health Research Organization at Temple University with the Humanitarian award at the foundation’s 31st Anniversary Gala.
12-Nov-2018 9:00 AM EST Add to Favorites


Dompé at the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” - October 13th, Washington, D.C

Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in...
13-Oct-2018 2:00 PM EDT Add to Favorites


Medical Conference: The Impact of Environment and Healthy Lifestyles in Human Health

The medical conference is organized by the Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano...
3-Oct-2018 9:00 AM EDT Add to Favorites


Healthier Planet, Healthier People, and More Innovative Medical Science with Italian-American Researchers at Annual NIAF Convention

Foundation Awards Presented for Ethics and Creativity in Medical Research, and Societal Impact in Business & Biotechnology
2-Oct-2018 9:00 AM EDT Add to Favorites

New MicroRNA Target May Inhibit Mesothelioma and Unveils Method to Identify Potential Treatments

Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma (MPM). The new potential target, and the method researchers have used to identify it, is an important step in...
24-Aug-2018 1:45 PM EDT Add to Favorites

see all news

Our Experts on Newswise


Understanding Cancer Heterogeneity Could Further Reduce Chemo Use, Says Expert

6-Jun-2018 11:35 AM EDT

Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert

16-Jan-2018 11:05 AM EST


Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT


Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.


Barbara Colombo

Antonio Giordano

Antonio Giordano


Our Multimedia on Newswise

Twitter twitter-icon

Chat now!